Try our beta test site
3 studies found for:    (lymphoma [CONDITION] OR CLL [CONDITION]) AND YM155 [TREATMENT]
Show Display Options
Rank Status Study
1 Terminated Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects
Conditions: Lymphoma, Large-Cell, Diffuse;   Lymphoma, B-Cell Refractory
Intervention: Drug: YM155
2 Completed A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: YM155;   Biological: Rituximab
3 Completed An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155
Conditions: Prostate Cancer;   Melanoma;   Non-Hodgkin's Lymphoma
Intervention: Drug: YM155

Study has passed its completion date and status has not been verified in more than two years.